Where can I buy shares of vygr?
Shares of VYGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What are the expectations for Voyager Therapeutics'stock's price?
11 brokerages have issued 12-month price objectives for Voyager Therapeutics' stock. Their forecasts range from $4.00 to $45.00. On average, they expect Voyager Therapeutics' share price to reach $12.78 in the next twelve months. This suggests a possible upside of 334.6% from the stock's current price.
Is Voyager Therapeutics (vygr) the fastest-growing company in North America?
The list, released Wednesday, ranks the fastest-growing technology, media, telecommunications and life sciences companies based in North America. Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 10.67% and -25.90%, respectively, for the quarter ended September 2021.
Why did Voyager’s shares rise 57% on Pfizer deal?
Just ask Voyager (VYGR) investors following Wednesday’s action. Shares gained 57% in the session after the micro-cap announced a deal with Pfizer that, in total, could be worth $630 million. Voyager entered into a License Option Agreement with the pharma giant for the potential use of two novel capsids generated from Voyager’s RNA-driven TR
See more
Is VYGR stock a good buy?
Voyager Therapeutics has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Why did VYGR stock drop?
Shares of the clinical-stage gene therapy company Voyager Therapeutics (VYGR 0.70%) dropped by as much as 11% in pre-market trading Tuesday morning. The biotech's shares are responding negatively to a regulatory delay for its Huntington's disease candidate, VY-HTT01.
Should I buy or sell Voyager Therapeutics stock right now?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Voyager Therapeutics in the last year. There are current...
What is Voyager Therapeutics' stock price forecast for 2022?
4 analysts have issued 1-year price objectives for Voyager Therapeutics' stock. Their forecasts range from $6.00 to $45.00. On average, they antici...
How has Voyager Therapeutics' stock performed in 2022?
Voyager Therapeutics' stock was trading at $2.71 at the beginning of the year. Since then, VYGR stock has increased by 100.4% and is now trading at...
When is Voyager Therapeutics' next earnings date?
Voyager Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for V...
How were Voyager Therapeutics' earnings last quarter?
Voyager Therapeutics, Inc. (NASDAQ:VYGR) posted its quarterly earnings data on Wednesday, May, 4th. The company reported ($0.56) earnings per share...
Who are Voyager Therapeutics' key executives?
Voyager Therapeutics' management team includes the following people: Dr. Glenn F. Pierce M.D. , Ph.D., Interim Chief Scientific Officer & Directo...
Who are some of Voyager Therapeutics' key competitors?
Some companies that are related to Voyager Therapeutics include Replimune Group (REPL) , Alector (ALEC) , Arcellx (ACLX) , Instil Bio (TIL) ,...
What other stocks do shareholders of Voyager Therapeutics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Voyager Therapeutics investors own include Micron Technolo...
What is Voyager Therapeutics' stock symbol?
Voyager Therapeutics trades on the NASDAQ under the ticker symbol "VYGR."
When will Voyager Therapeutics release its earnings?
What is the NASDAQ symbol for Voyager Therapeutics?
Voyager Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021. View our earnings forecast for Voyager Therapeutics.
How much does Voyager Therapeutics make?
Voyager Therapeutics trades on the NASDAQ under the ticker symbol "VYGR."
What is the official website of Voyager Therapeutics?
Voyager Therapeutics has a market capitalization of $117.71 million and generates $171.13 million in revenue each year. The company earns $36.74 million in net income (profit) each year or $0.98 on an earnings per share basis.
What is Voyager Therapeutics?
The official website for Voyager Therapeutics is www.voyagertherapeutics.com.
Is Voyager Therapeutics a hold?
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.
Does Voyager Therapeutics pay dividends?
Wall Street analysts have given Voyager Therapeutics a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Voyager Therapeutics wasn't one of them.
Vertex Pharmaceuticals (VRTX) Surpasses Q4 Earnings and Revenue Estimates
Voyager Therapeutics does not currently pay a dividend.
Shareholders in Voyager Therapeutics (NASDAQ:VYGR) are in the red if they invested five years ago
Vertex (VRTX) delivered earnings and revenue surprises of 2.74% and 4.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
These 40 Mass. companies made the new Deloitte Fast 500 list
Long term investing works well, but it doesn't always work for each individual stock. We really hate to see fellow...
How long are futures trading delayed?
The list, released Wednesday, ranks the fastest-growing technology, media, telecommunications and life sciences companies based in North America.
How often do exchanges report short interest?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Source: FactSet
Which stocks have the highest correlation with VYGR?
Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
What is the EV/EBIT ratio of Vygr?
JAGX, SGEN, and OTLC are the stocks whose asset turnover ratios are most correlated with VYGR.
What is the PEG ratio of Voyager Therapeutics?
VYGR's EV/EBIT ratio is 0.3; this is 98.98% lower than that of the median Healthcare stock.
